ACTBL2, actin beta like 2, 345651

N. diseases: 134; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0578870
Disease: Chronic idiopathic urticaria
Chronic idiopathic urticaria
0.010 Biomarker disease BEFREE The X-ACT study aimed to examine the effect of omalizumab treatment on quality of life (QoL) in chronic spontaneous urticaria (CSU) patients with angioedema refractory to high doses of H<sub>1</sub> -antihistamines. 29058822 2018